California Non-Local Sources CA

Trial of experimental Alzheimer's drug shows slower decline, safety concerns

UPI on California

Nov 30, 2022

The experimental Alzheimer's drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelli…

Read the full story at UPI on California

Trial of experimental Alzheimer's drug shows slower decline, safety concerns

More from California Non-Local Sources

Life-sentenced rapist who called break-in attack his 'Super Bowl' wins early release after just a decade

FBI offers $1M reward for capture of 'Ten Most Wanted' 300-pound suspect possibly hiding in Mexico

California bishop's alleged secret double life explodes into felony case

At least 40 percent of California teachers plan to quit in the next decade: survey

California professor calls to abolish identities like 'gay' and 'lesbian' since they 'harm trans people'

California House Republican announces he's leaving GOP immediately, thinning slim majority

Former SJSU volleyball star opens up on living with trans teammate without knowing athlete's biological sex

Trump admin squashes controversial Biden rule forcing foster homes to affirm children's LGBTQ+ status